March Madness, the colloquial name for the NCAA men’s Basketball Tournament, is aptly named for a variety of reasons, whether it be for the nail-biting, heart-attack-inducing-finishes, or the decrease in worker productivity during the tournament season. The NCAA tournament truly induces Madness. However, perhaps the real reason March Madness is an apt name is because of the sports betting that occurs during the tournament season, with an estimated more than $3 billion wagered.Continue Reading

For decades, drug discovery has been known to be an immense investment with low odds of success. The costs of research and development (R&D) alone are notably high, averaging out to be $1.3 billion per drug in the United States. And yet, despite this funding, out of the tens of thousands of drug candidates that seek approval by the FDA each year, generally only 40 to 50 are successful. Life sciences company Schrödinger is attempting to expedite this process.Continue Reading

From Trader Joe’s to Cargill, many of America’s most popular and lucrative companies are not available for retail investors to purchase. What does it say about the stock market that the vast majority of companies in America are privately held? In this short article, Senior Investing Columnist Abby Copeland will explain why many top businesses are privately held and the advantages and disadvantages that non-public companies hold.Continue Reading

Aimed at enforcing objectifying and streamlining risk assessment processes, AI-based lending systems bring new benefits for both lenders and consumers within the lending market, along with risks and imperfections. This article sets out to explore the mechanism of AI-based underwriting, as well as its future implications.Continue Reading